Bayer Spend On Start-Ups Growing By Leaps And Bounds
Ramps Up Investment Cashpile
The German group is putting another €1.3bn into its Leaps by Bayer investment arm until the end of 2024 to support new companies that are "shifting core paradigms in the sectors of health and agriculture."
